Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4852-4856

  Tai, Pei Ching ^a   Banik, Dana ^a   Lin, Gen Iu ^a   Pai, Shan ^a   Pai, Kan ^a   Lin, Min Hui ^a   Yuoh, Gbo ^a   Che, Shaoli ^a   Hsu, Susan H ^b   Chen, Tse Ching ^c   Kuo, Tseng Tong ^c   Lee, Chue Shue ^d   Yang, Czau Siung ^d   Shih, Chiaho ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b AMERICAN RED CROSS   (United States)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; LIVER; LIVER CELL CARCINOMA; MALE; MUTATION RATE; PERSISTENT INFECTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS CARRIER;

EID: 0030925302     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4852-4856.1997     Document Type: Article

References (35)

1. Barnaba, V., A. Franco, M. Paroli, R. Benvenuto, G. De Petrillo, V. L. Burgio, I. Santilio, C. Balsano, M. S. Bonavita, G. Cappelli, V. Colizzi, G. Gutrona, and M. Ferrarini. 1994. Selective expansion of cytotoxic T lymphocytes with a CD4+ CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J. Immunol. 152:3074-3087.
2. Blumberg, B. S. 1964. Polymorphisms of the serum proteins and the development of isoprccipitins in transfused patients. Bull. N. Y. Acad. Med. 40:377-386.
3. Bozkaya, H., B. Ayola, and A. S. F. Lok. 1996. High rate of mutations in the hepatitis core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology 24:32-37.
4. Bruce, S. A., and K. Murray. 1995. Mutations of some critical amino acid residues in the hepatitis B virus surface antigen. J. Med. Virol. 46:157-161.
5. Carman, W. F., J. Korula, L. Wallace, R. MacPhee, L. Mimms, and R. Decker. 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345: 1406-1407.
6. Celis, E., D. Ou, and L. Otvos. 1988. Recognition of hepatitis B surface antigen by human T lymphocytes: proliferation and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J. Immunol. 140: 1808-1815.
7. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
8. Chopek, M. 1995. DNA typing for class I, abstr. 216, p. 151. In ASHI (American Society of Histocompatibility and Immunogenetics) 21st Annual Meeting Workshop 17, 6 to 11 October 1995, Dallas, Tex.
9. Hilleman, M. R. 1993. Plasma-derived hepatitis B vaccine: a breakthrough in preventive medicine, p. 17-39. In R. Ellis (ed.), Hepatitis B vaccines in clinical practice. Marcel Dekker, New York, N.Y.
10. Hosono, S., P.-C. Tai, W. Wang, M. Ambrose, D. G.-Y. Hwang, T.-T. Yuan, B.-H. Peng, C.-S. Yang, C.-S. Lee, and C. Shih. 1995. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology 212:151-162.
11. Karthigesu, V. D., L. M. C. Allison, M. Fortuin, M. Mendy, H. C. Whittle, and C. R. Howard. 1994. A novel hepatitis B virus variant in the sera of immunized children. J. Gen. Virol. 75:443-448.
12. Lee, Y. I. K., G. M. Hur, D. J. Suh, and S. H. Kim. 1996. Novel preC/C gene mutants of hepatitis B virus in chronic active hepatitis: naturally occurring escape mutants. J. Gen. Virol. 77:1129-1138.
13. Maruyama, T., A. McLachlan, S. Lino, K. Koike, and D. Milich. 1993. The serology of chronic hepatitis B infection revisited. J. Clin. Invest. 91:2586-2595.
14. McMahon, G,. P. H. Ehrlich, Z. A. Moustafa, L. A. McCarthy, D. Dottavio, M. D. Tolpin, P. I. Nadler, and L. Ostberg. 1992. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757-766.
15. Min, W.-P., N. Kamikawaji, M. Mineta, T. Tana, S. Kashinagi, and T. Sasazuki. 1996. Identification of an epitope for T-cells correlated with antibody response to hepatitis B surface antigen in vaccinated humans. Hum. Immunol. 46:93-99.
16. Minami, M., K. Poussin, M. Kew, T. Okanoue, C. Brechot, and P. Paterlini. 1996. Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed on noncirrhotic livers. Gastroenterology 111:691-700.
17. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H. J. Schlich, A. Vitiello, R. Chesnut, J. L. Person, A. G. Redeker, and F. V. Chisari. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.
18. Norder, H., B. Hammas, S. D. Lee, K. Bile, A. M. Courouce, I. K. Mushahwar, and L. O. Magnius. 1993. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J. Gen. Virol. 74:1341-1348.
19. Peterson, D. L., N. Nath, and F. Gavilanes. 1982. Structure of hepatitis B surface antigen. J. Biol. Chem. 257:10414-10420.
20. Pircher, H., D. Moskophidis, U. Rohrer, K. Burki, H. Hengartne, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633.
21. Purcell, R. H., and J. L. Gerin. 1978. Hepatitis B vaccines: on the threshold. Am. J. Clin. Pathol. 70:159-169.
22. Schirmbeck, R., K. Melber, and J. Reinmann. 1995. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatihility complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1063-1070.
23. Shafritz, D. A., D. Shouval, H. I. Sherman, S. J. Hadziyannis, and M. C. Kew. 1981. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N. Engl. J. Med. 305:1067-1073.
24. Shih, C., K. Burke, J. Zeldis, J. Wands, K. J. Isselbacher, M. J. Chou, C. S. Yang, C. S. Lee, and H. M. Goodman. 1987. Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J. Virol. 61:3491-3498.
25. Shih, C., P.-C. Tai, W. Whitehead, S. Hosono, C.-S. Lee, and C.-S. Yang. 1996. Hepatitis B and C viruses and liver cancer, p. 824-834. In J. R. Bertino (ed.), Encyclopedia of cancer, vol. II. Academic Press, Inc., San Diego, Calif.
26. Shu, P. Y., M. Y. Lin, C. Chang, L. H. Hwang, J. H. Huang, T. H. Chang, and C. Hu. 1994. Presence of hepatitis B surface antigen (HBsAg)-specific cytotoxic T cells in asymptomatic HBsAg carriers. J. Infect. Dis. 169:633-637.
27. Sung, J. L. 1981. Hepatitis B virus infection and its sequelae in Taiwan. Proc. Natl. Sci. Counc. Repuh. China Part B 5:385-399.
28. Sung, J. L., and D. S. Chen. 1977. Geographical distribution of the subtype of hepatitis B surface antigen in Chinese. Gastroenterol. Jpn. 12:58-63.
29. Szmuness, W., C. E. Stevens, E. J. Harley, E. A. Zang, W. R. Oleszko, D. C. William, R. Sadovsky, J. M. Morrison, and A. Kellner. 1980. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N. Engl. J. Med. 303:833-841.
30. Tiollais, P., C. Pourcel, and A. Dejean. 1985. The hepatitis B virus. Nature 317:489-495.
31. Tissue Antigen Laboratory. 1995. Twelfth International Histocompatibility Workshop: HLA class I SSP ARMS-PCR typing kit, reference manual, June 1995 ed. Tissue Antigen Laboratory, Imperial Cancer Research Fund, London, United Kingdom.
32. Vyas, G. N., D. R. Rao, and A. B. Ibrahim. 1972. Australia antigen (hepatitis B antigen). A conformational antigen dependent on disulfide bonds. Science 178:1300.
33. Waters, J. A., M. Kennedy, P. Voet, P. Hauser, J. Petre, W. Carman, and H. C. Thomas. 1992. Loss of the common "a" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Invest. 90:2543-2547.
34. Yamamoto, K., M. Horikita, F. Tsuda, K. Itoh, Y. Akahane, S. Yotsumoto, H. Okamoto, Y. Miyakawa, and M. Mayumi. 1994. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J. Virol. 68:2671-2676.
35. Zanetti, A. R., E. Tanzi, G. Manzillo, G. Mai, C. Sbreglia, N. Caporaso, H. Thomas, and A. J. Zuckerman. 1988. Hepatitis B variants in Europe. Lancet ii:1132-1133.